Nuance Investments LLC reduced its holdings in shares of The Clorox Company (NYSE:CLX – Free Report) by 18.1% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 694,817 shares of the company’s stock after selling 153,289 shares during the period. Clorox comprises about 8.7% of Nuance Investments LLC’s investment portfolio, making the stock its biggest position. Nuance Investments LLC owned 0.57% of Clorox worth $85,671,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Canvas Wealth Advisors LLC lifted its stake in Clorox by 17.7% during the third quarter. Canvas Wealth Advisors LLC now owns 34,788 shares of the company’s stock worth $4,286,000 after purchasing an additional 5,240 shares during the period. Azzad Asset Management Inc. ADV raised its holdings in shares of Clorox by 1.4% in the 3rd quarter. Azzad Asset Management Inc. ADV now owns 20,287 shares of the company’s stock worth $2,501,000 after buying an additional 287 shares in the last quarter. Moloney Securities Asset Management LLC lifted its position in shares of Clorox by 26.5% during the 3rd quarter. Moloney Securities Asset Management LLC now owns 11,967 shares of the company’s stock worth $1,476,000 after buying an additional 2,507 shares during the period. Wellington Shields Capital Management LLC acquired a new stake in Clorox in the 3rd quarter valued at $65,000. Finally, Wellington Shields & Co. LLC bought a new stake in Clorox in the third quarter valued at $173,000. Institutional investors own 78.53% of the company’s stock.
Wall Street Analysts Forecast Growth
CLX has been the topic of several recent analyst reports. Evercore reduced their target price on shares of Clorox from $132.00 to $115.00 and set an “underperform” rating on the stock in a research note on Wednesday, February 4th. Rothschild & Co Redburn reduced their price target on shares of Clorox from $120.00 to $115.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 5th. BNP Paribas Exane dropped their price objective on shares of Clorox from $103.00 to $101.00 and set an “underperform” rating for the company in a report on Friday, January 16th. Citigroup boosted their target price on Clorox from $109.00 to $115.00 and gave the stock a “neutral” rating in a report on Wednesday. Finally, TD Cowen increased their price target on Clorox from $108.00 to $111.00 and gave the stock a “hold” rating in a research report on Wednesday, February 4th. One equities research analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and five have given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Reduce” and a consensus target price of $117.93.
Clorox Price Performance
CLX opened at $119.52 on Monday. The company has a debt-to-equity ratio of 71.03, a current ratio of 0.74 and a quick ratio of 0.48. The stock has a market capitalization of $14.45 billion, a P/E ratio of 19.53, a price-to-earnings-growth ratio of 0.59 and a beta of 0.59. The company’s 50 day simple moving average is $105.83 and its 200-day simple moving average is $113.73. The Clorox Company has a one year low of $96.66 and a one year high of $159.04.
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings data on Tuesday, February 3rd. The company reported $1.39 EPS for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). The firm had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a net margin of 11.17% and a return on equity of 383.01%. The firm’s quarterly revenue was down .8% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.55 earnings per share. Sell-side analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current fiscal year.
Clorox Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 28th will be given a dividend of $1.24 per share. The ex-dividend date is Wednesday, January 28th. This represents a $4.96 annualized dividend and a dividend yield of 4.1%. Clorox’s payout ratio is currently 81.05%.
Key Clorox News
Here are the key news stories impacting Clorox this week:
- Positive Sentiment: Morgan Stanley raised its price target on CLX to $136 (maintained equal-weight), citing valuation/earnings dynamics — a catalyst supporting the stock’s rally. Clorox (NYSE:CLX) Price Target Raised to $136.00 at Morgan Stanley
- Positive Sentiment: Investor write-ups are bullish: a Seeking Alpha piece frames CLX as a defensive, dividend-rich value after “solid” Q2 results and attractive valuation — supporting buy interest from income-focused investors. Clorox: Solid Q2 Results And Cheap Valuation MakesThis Defensive Dividend Stock A Strong Buy
- Neutral Sentiment: TD Cowen nudged its price target to $111 and kept a Hold rating — a modest recalibration that tempers upside expectations despite the recent positive headlines. TD Cowen Adjusts Clorox Price Target
- Neutral Sentiment: Company reported mixed Q2 results and reaffirmed its 2026 outlook — revenue roughly flat year-over-year and an EPS miss by a few cents; reassurances on the outlook limit downside but leave questions on near-term margin recovery. Clorox Posts Mixed Q2 Results, Reaffirms 2026 Outlook
- Neutral Sentiment: Management is weighing a potential GOJO acquisition and finishing an ERP implementation; strategic moves could boost long-term growth but add execution risk in the near term. Clorox Weighs GOJO Deal And ERP Finish Against Softer Earnings
- Neutral Sentiment: Q2 earnings call transcript is available for deeper read on management commentary around pricing, cost savings and margin plans — useful for gauging execution risk. Clorox (CLX) Q2 2026 Earnings Call Transcript
- Negative Sentiment: Some brokerages have a consensus “Reduce” rating on CLX, which may cap upside as institutional flows react to conservative guidance and margin concerns. The Clorox Company Given Consensus Rating of “Reduce” by Brokerages
- Negative Sentiment: BofA flagged margin uncertainty after the Q2 EPS miss — a reminder that cost and margin recovery, not just revenue, will drive forecast revisions and investor sentiment. BofA Flags Margin Uncertainty for Clorox After Q2 Earnings Miss
- Neutral Sentiment: A Zacks piece highlights using its Earnings ESP tool to find staples stocks that might beat — general market research, not CLX-specific guidance, but could affect short-term trading interest. Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now
Insider Buying and Selling at Clorox
In other Clorox news, Director Pierre R. Breber acquired 4,000 shares of the business’s stock in a transaction that occurred on Friday, November 21st. The shares were acquired at an average cost of $104.13 per share, for a total transaction of $416,520.00. Following the completion of the acquisition, the director directly owned 13,000 shares of the company’s stock, valued at approximately $1,353,690. This represents a 44.44% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.63% of the stock is currently owned by company insiders.
About Clorox
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
See Also
- Five stocks we like better than Clorox
- The day the gold market broke
- Your Bank Account Is No Longer Safe
- What a Former CIA Agent Knows About the Coming Collapse
- He just nailed another gold prediction …
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
